Daina Skiriute

Summary

Publications

  1. doi request reprint Tumor grade-related NDRG2 gene expression in primary and recurrent intracranial meningiomas
    Daina Skiriute
    Laboratory of Neuroscience, Institute for Biomedical Research of Kaunas University of Medicine, Eiveniu str 4, Kaunas 50161, Lithuania
    J Neurooncol 102:89-94. 2011
  2. doi request reprint Promoter methylation of AREG, HOXA11, hMLH1, NDRG2, NPTX2 and Tes genes in glioblastoma
    Daina Skiriute
    Laboratory of Neurooncology and Genetics, Neuroscience Institute, Lithuanian University of Health Sciences, Eiveniu str 4, 50161 Kaunas, Lithuania
    J Neurooncol 113:441-9. 2013
  3. pmc MGMT, GATA6, CD81, DR4, and CASP8 gene promoter methylation in glioblastoma
    Daina Skiriute
    Laboratory of Neurooncology and Genetics, Neuroscience Institute, Medical Academy, Lithuanian University of Health Sciences, Eiveniu str, 4, Kaunas, LT, 50009, Lithuania
    BMC Cancer 12:218. 2012
  4. ncbi request reprint Associations between TFPI-2 methylation and poor prognosis in glioblastomas
    Paulina Vaitkiene
    Laboratory of Neurooncology and Genetics, Neuroscience Institute, Medical Academy, Lithuanian University of Health Sciences, Eiveniu 4, 50161 Kaunas, Lithuania
    Medicina (Kaunas) 48:345-9. 2012
  5. pmc GATA4 and DcR1 methylation in glioblastomas
    Paulina Vaitkiene
    Laboratory of Neurooncology and Genetics, Neuroscience Institute, Kaunas Academy of Medicine, Lithuanian University of Health Sciences, Eiveniu str 4, Kaunas, LT, Lithuania
    Diagn Pathol 8:7. 2013
  6. ncbi request reprint A primary primitive neuroectodermal tumor of the central nervous system in a 51-year-old woman: a case report and literature review
    Virginija Asmoniene
    Neuroscience Institute, Medical Academy, Lithuanian University of Health Sciences, Eiveniu 4, 50161 Kaunas, Lithuania
    Medicina (Kaunas) 47:440-5. 2011
  7. pmc Glioma Malignancy-Dependent NDRG2 Gene Methylation and Downregulation Correlates with Poor Patient Outcome
    Daina Skiriute
    1 1 Laboratory of Neurooncology and Genetics, Neuroscience Institute, Medical Academy, Lithuanian University of Health Sciences, Eiveniu str 4, LT 50009, Kaunas, Lithuania
    J Cancer 5:446-56. 2014
  8. pmc High level of Sema3C is associated with glioma malignancy
    Paulina Vaitkiene
    Laboratory of Neurooncology and Genetics, Neuroscience Institute, Lithuanian University of Health Sciences, Eiveniu str 4, Kaunas, LT 50009, Lithuania
    Diagn Pathol 10:58. 2015
  9. doi request reprint Transsphenoidal surgery for microprolactinomas in women: results and prognosis
    Arimantas Tamasauskas
    Laboratory of Neurooncology and Genetics, Institute of Neurosciences, Eiveniu g 4, Kaunas, Lithuania
    Acta Neurochir (Wien) 154:1889-93. 2012

Collaborators

Detail Information

Publications9

  1. doi request reprint Tumor grade-related NDRG2 gene expression in primary and recurrent intracranial meningiomas
    Daina Skiriute
    Laboratory of Neuroscience, Institute for Biomedical Research of Kaunas University of Medicine, Eiveniu str 4, Kaunas 50161, Lithuania
    J Neurooncol 102:89-94. 2011
    ..In accordance with our results, reduction of NDRG2 gene expression at the mRNA level could help to explain malignant progression and predisposition to recurrence in meningiomas...
  2. doi request reprint Promoter methylation of AREG, HOXA11, hMLH1, NDRG2, NPTX2 and Tes genes in glioblastoma
    Daina Skiriute
    Laboratory of Neurooncology and Genetics, Neuroscience Institute, Lithuanian University of Health Sciences, Eiveniu str 4, 50161 Kaunas, Lithuania
    J Neurooncol 113:441-9. 2013
    ..AREG gene might be valuable marker for glioblastoma patient survival prognosis, however further analysis is needed to clarify the independence and appropriateness of the marker...
  3. pmc MGMT, GATA6, CD81, DR4, and CASP8 gene promoter methylation in glioblastoma
    Daina Skiriute
    Laboratory of Neurooncology and Genetics, Neuroscience Institute, Medical Academy, Lithuanian University of Health Sciences, Eiveniu str, 4, Kaunas, LT, 50009, Lithuania
    BMC Cancer 12:218. 2012
    ..Our aim was to study promoter methylation of newly identified epigenetically silenced genes together with already known epigenetic markers and evaluate its separate and concomitant role in glioblastoma genesis and patient outcome...
  4. ncbi request reprint Associations between TFPI-2 methylation and poor prognosis in glioblastomas
    Paulina Vaitkiene
    Laboratory of Neurooncology and Genetics, Neuroscience Institute, Medical Academy, Lithuanian University of Health Sciences, Eiveniu 4, 50161 Kaunas, Lithuania
    Medicina (Kaunas) 48:345-9. 2012
    ..In this study, we aimed to investigate the methylation status of TFPI-2 promoter and its associations with patient prognosis in glioblastoma...
  5. pmc GATA4 and DcR1 methylation in glioblastomas
    Paulina Vaitkiene
    Laboratory of Neurooncology and Genetics, Neuroscience Institute, Kaunas Academy of Medicine, Lithuanian University of Health Sciences, Eiveniu str 4, Kaunas, LT, Lithuania
    Diagn Pathol 8:7. 2013
    ..In this study, we investigated methylation of GATA4 and DcR1 promoters and their association with patient prognosis in glioblastoma...
  6. ncbi request reprint A primary primitive neuroectodermal tumor of the central nervous system in a 51-year-old woman: a case report and literature review
    Virginija Asmoniene
    Neuroscience Institute, Medical Academy, Lithuanian University of Health Sciences, Eiveniu 4, 50161 Kaunas, Lithuania
    Medicina (Kaunas) 47:440-5. 2011
    ..The article presents a short literature review and a rare case of a primary primitive neuroectodermal tumor of the central nervous system diagnosed in a 51-year-old woman...
  7. pmc Glioma Malignancy-Dependent NDRG2 Gene Methylation and Downregulation Correlates with Poor Patient Outcome
    Daina Skiriute
    1 1 Laboratory of Neurooncology and Genetics, Neuroscience Institute, Medical Academy, Lithuanian University of Health Sciences, Eiveniu str 4, LT 50009, Kaunas, Lithuania
    J Cancer 5:446-56. 2014
    ..The aim of the study was to investigate how changes in epigenetic modification and activity of NDRG2 reflect on glioma malignancy and patient outcome...
  8. pmc High level of Sema3C is associated with glioma malignancy
    Paulina Vaitkiene
    Laboratory of Neurooncology and Genetics, Neuroscience Institute, Lithuanian University of Health Sciences, Eiveniu str 4, Kaunas, LT 50009, Lithuania
    Diagn Pathol 10:58. 2015
    ..The role of Sema3C in gliomagenesis is currently unclear. In this study, we investigated how expression levels of Sema3C in post-operative glioma tumors are associated with the malignancy grade and the survival of the patient...
  9. doi request reprint Transsphenoidal surgery for microprolactinomas in women: results and prognosis
    Arimantas Tamasauskas
    Laboratory of Neurooncology and Genetics, Institute of Neurosciences, Eiveniu g 4, Kaunas, Lithuania
    Acta Neurochir (Wien) 154:1889-93. 2012
    ..However, DA therapy may be poorly tolerated by some patients, and therefore some patients continue to prefer surgery over DA therapy...